Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Quanterix Corp

Get SEC filing alerts via email and in your feed for Quanterix Corp

QTRX

Quanterix Corp

About Quanterix Corp

Quanterix is a life sciences company specializing in ultra-sensitive digital immunoassay platforms based on proprietary Simoa technology. Its core business involves developing and selling instruments, consumables, and assay kits for protein biomarker detection in blood and fluids, serving research, biotech, and clinical markets. The company advances early disease detection, diagnostics, and biomarker research, with applications in neurology, oncology, immunology, and inflammation.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Quanterix Corp

1
1
Quanterix Corp Quanterix Reports $36.4M Revenue in Q1 2026, Driven by Product Growth and Acquisition

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Quanterix Corp Quanterix Reports $138.9 Million Revenue with Increased Losses in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Quanterix Corp Quanterix Reports 12% Revenue Growth to $40.2 Million in Q3 2025, Despite Increased Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Quanterix Corp Quanterix Reports 29% Revenue Decline and $30M Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Quanterix Corp Quanterix Reports $30.3 Million Revenue, Net Loss of $20.5 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Quanterix Corp Quanterix Reports $137.4M Revenue, 12% Growth, and Plans Merger with Akoya Biosciences

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Quanterix Corp Quanterix Reports 13% Revenue Growth to $35.8 Million in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments